Eli Lilly (LLY) Stock Trades Up, Here Is Why [Yahoo! Finance]
Eli Lilly and Company (LLY)
Last eli lilly and company earnings: 4/23 06:25 am
Check Earnings Report
US:NYSE Investor Relations:
investor.lilly.com
Company Research
Source: Yahoo! Finance
results that beat Wall Street expectations and issued an upbeat forecast for 2026, driven by high demand for its weight-loss drugs. The pharmaceutical company's revenue grew 42.6% year-over-year to $19.29 billion, surpassing analysts' estimates. Adjusted earnings per share came in at $7.54, which was also well above expectations. This strong performance was fueled by soaring sales of its popular weight-loss and diabetes drugs, Zepbound and Mounjaro. Looking ahead, Eli Lilly provided a positive outlook for 2026, forecasting revenue of $81.5 billion at the midpoint and adjusted earnings per share of $34.25 at the midpoint. Both projections were higher than what analysts had predicted. Is now the time to buy Eli Lilly? Access our full analysis report here, it's free Eli Lilly's shares are not very volatile and have only had 9 moves greater than 5% over the last year. In that context, today's move indicates the market considers this news meaningful, although it might not be somethin
Show less
Read more
Impact Snapshot
Event Time:
LLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LLY alerts
High impacting Eli Lilly and Company news events
Weekly update
A roundup of the hottest topics
LLY
News
- Eli Lilly and Company (LLY) Q4 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Eli Lilly Stock Soars While Novo Nordisk Sinks—Why the Weight-Loss Leaders Are Headed in Opposite Directions [Yahoo! Finance]Yahoo! Finance
- Eil Lilly shares jump on strong GLP-1 sales, as Novo Nordisk tumbles [Yahoo! Finance]Yahoo! Finance
- Eli Lilly's GLP-1 growth is only getting started as Novo Nordisk braces for a decline in 2026 [CNBC]CNBC
- We're raising our price target on Eli Lilly as the GLP-1 leader delivers a huge beat [CNBC]CNBC
LLY
Earnings
- 2/4/26 - Beat
LLY
Sec Filings
- 2/4/26 - Form 8-K
- 2/3/26 - Form 4
- 2/3/26 - Form 4
- LLY's page on the SEC website